These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 25872744
1. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals. Setiawan LC, Gijsbers EF, van Nuenen AC, Kootstra NA. J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744 [Abstract] [Full Text] [Related]
2. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, Kuntzen T, Tung CS, LaBute MX, Mueller SM, Harrer T, McMichael AJ, Goulder PJ, Aiken C, Brander C, Kelleher AD, Allen TM. J Virol; 2007 Nov; 81(22):12382-93. PubMed ID: 17804494 [Abstract] [Full Text] [Related]
3. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. Schneidewind A, Brockman MA, Sidney J, Wang YE, Chen H, Suscovich TJ, Li B, Adam RI, Allgaier RL, Mothé BR, Kuntzen T, Oniangue-Ndza C, Trocha A, Yu XG, Brander C, Sette A, Walker BD, Allen TM. J Virol; 2008 Jun; 82(11):5594-605. PubMed ID: 18385228 [Abstract] [Full Text] [Related]
4. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. Payne RP, Kløverpris H, Sacha JB, Brumme Z, Brumme C, Buus S, Sims S, Hickling S, Riddell L, Chen F, Luzzi G, Edwards A, Phillips R, Prado JG, Goulder PJ. J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036 [Abstract] [Full Text] [Related]
5. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes. Murakoshi H, Akahoshi T, Koyanagi M, Chikata T, Naruto T, Maruyama R, Tamura Y, Ishizuka N, Gatanaga H, Oka S, Takiguchi M. J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000 [Abstract] [Full Text] [Related]
7. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD. J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335 [Abstract] [Full Text] [Related]
8. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection. Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, Miedema F, Kootstra N, Schuitemaker H. J Immunol; 2007 Sep 01; 179(5):3133-43. PubMed ID: 17709528 [Abstract] [Full Text] [Related]
12. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. Feeney ME, Tang Y, Roosevelt KA, Leslie AJ, McIntosh K, Karthas N, Walker BD, Goulder PJ. J Virol; 2004 Aug 01; 78(16):8927-30. PubMed ID: 15280502 [Abstract] [Full Text] [Related]
13. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, Conlon C, Workman C, Shaunak S, Olson K, Goulder P, Brander C, Ogg G, Sullivan JS, Dyer W, Jones I, McMichael AJ, Rowland-Jones S, Phillips RE. J Exp Med; 2001 Feb 05; 193(3):375-86. PubMed ID: 11157057 [Abstract] [Full Text] [Related]
14. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control. Caetano DG, Côrtes FH, Bello G, Teixeira SLM, Hoagland B, Grinsztejn B, Veloso VG, Guimarães ML, Morgado MG. Retrovirology; 2018 Sep 10; 15(1):62. PubMed ID: 30201008 [Abstract] [Full Text] [Related]
15. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. Cornelissen M, Hoogland FM, Back NK, Jurriaans S, Zorgdrager F, Bakker M, Brinkman K, Prins M, van der Kuyl AC. AIDS; 2009 Jul 31; 23(12):1495-500. PubMed ID: 19487902 [Abstract] [Full Text] [Related]
16. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection. Sunshine JE, Larsen BB, Maust B, Casey E, Deng W, Chen L, Westfall DH, Kim M, Zhao H, Ghorai S, Lanxon-Cookson E, Rolland M, Collier AC, Maenza J, Mullins JI, Frahm N. J Virol; 2015 Oct 31; 89(20):10303-18. PubMed ID: 26223634 [Abstract] [Full Text] [Related]
19. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. Klein MR, van der Burg SH, Hovenkamp E, Holwerda AM, Drijfhout JW, Melief CJ, Miedema F. J Gen Virol; 1998 Sep 31; 79 ( Pt 9)():2191-201. PubMed ID: 9747728 [Abstract] [Full Text] [Related]
20. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF. PLoS One; 2007 Feb 21; 2(2):e225. PubMed ID: 17311088 [Abstract] [Full Text] [Related] Page: [Next] [New Search]